The diagnosis of atypical<unk>  rhabdoid<unk>  is based on the current WHO classification of<unk> s of the central nervous system criteria, which include presence of rhabdoid<unk>  cells and/or divergent differentiation along epithelial, mesenchymal, neuronal, or glial lines in addition to the complete loss of SMARCB1 protein expression in<unk>  cell nuclei, but the expression retained in preexisting cells (e.g., endothelial cells).
Atypical teratoid rhabdoid tumor diagnostic study of choice
Atypical teratoid rhabdoid tumor other diagnostic studies
Atypical teratoid rhabdoid tumor other imaging findings
Neuroblastoma other diagnostic studies
Esthesioneuroblastoma other diagnostic studies
Germinoma other diagnostic studies
Ameloblastoma other diagnostic studies
Neuroblastoma other imaging findings